Insights
Field notes on trial activation, regulatory validation, and jurisdictional strategy — from the team building the category.
Verification vs. Authoring vs. Orchestration: The Three Camps of Clinical-Trial AI
Clinical-trial AI splits into three camps — authoring, orchestration, and verification. Only one produces evidence that survives inspection.
How to Bring a Clinical Trial to Brazil Under Brazil's New Regulatory System
Brazil rewrote its clinical trial rules in 2024 and cut review timelines. Here is the ANVISA fast track, the new SINEP ethics system, and how foreign sponsors qualify.
How to Use a Clinical Trial Run in Brazil to Support US FDA Approval
How Brazil-run data supports a US FDA submission, and where it fails inspection.
Clinical Trial Activation in India: Where the Friction Actually Sits
India's regulatory clock is faster than most sponsors expect. Activation still takes quarters. The friction sits downstream of CDSCO, in registry reconciliation, ethics committee status, and site qualification.
How a CRO Qualifies an AI Vendor Under Its Own Quality System
Sponsors have started putting AI questions into CRO RFPs. Most quality units have no validated answer. Here is what the question is actually asking, and the eight questions to put to any vendor.
The Regulatory Validation Framework
A verification-architecture framework for validating AI that drafts, verifies, and coordinates clinical trial decisions across FDA, EU, ANVISA, and CDSCO.
CFM 2.454 Regulates the Physician, Not the Software. What That Means for Your Brazilian Sites
Brazil's AI resolution takes effect 26 August 2026. It binds doctors and institutions, not vendors. Your EU or FDA file does not travel.
What Your Institution Must Be Able to Demonstrate From 26 August, and What to Require From Every AI Supplier
CFM Resolution 2.454/2026 takes effect 26 August. Risk classification, a committee, a record discipline, and evidence from your suppliers.
The AI Tools Used to Speed Up Clinical Trial Activation, and the Layer None of Them Occupy
A neutral map of the AI tools working on clinical trial activation, grouped by what they actually do, and the one layer the field has left mostly empty.
Provably Right, Not Probably Right
A confidence score cannot be reconstructed under inspection. A proof certificate can. Why regulated clinical AI needs proof, not probability, defined.